HIT Consultant

MAY 9, 2023

For any practitioner-patient telemedicine relationships that have been or will be established up to November 11, 2023, the full set of telemedicine flexibilities regarding the prescription of controlled medications established during the COVID-19 PHE will be extended for one year – through November 11, 2024.

COVID-19 98

COVID-19 Telemedicine Public Health Health Services Administration 98

Healthcare IT News - Telehealth

MAY 10, 2023

Department of Health and Human Services said it would temporarily extend telemedicine flexibilities for the prescription of certain controlled medications granted under the COVID-19 Public Health Emergency, which is set to expire on May 11. This past week, the U.S. Drug Enforcement Agency and the U.S.

Telemedicine 157

Telemedicine COVID-19 Health Services Administration Public Health 157

Bill of Health

NOVEMBER 15, 2023

health care system, but that are especially present for behavioral health needs like substance use, and are exacerbated by other challenges related to stigma, lack of employment, and fragmented or nonexistent care coordination. This reality reflects structural, policy, and legal misalignments common to the entire U.S.

Governance 173

Governance Public Health Telemedicine COVID-19 173

Healthcare Law Blog

OCTOBER 17, 2023

Under the Second Temporary Rule, practitioners may continue to prescribe schedule II-V controlled medications via telemedicine for new and existing patients without conducting a prior in-person medical evaluation through 2024. Sheppard Mullin will continue to monitor developments and provide updates as they arise.

Telemedicine 52

Telemedicine COVID-19 Health Services Administration Public Health 52

Health Law Advisor

MARCH 7, 2023

The proposed rules are more restrictive than the DEA emergency waivers under which providers conducted telemedicine prescribing for the last three years, but are less restrictive in comparison to the pre-PHE regulations applicable to telemedicine prescribing of controlled substances under the federal Controlled Substances Act (“CSA”).

Telemedicine 52

Telemedicine COVID-19 FDA Compliance 52

Hall Render

MAY 9, 2023

Notably, the Temporary Rule, which can be accessed here , extends the COVID-19 PHE telemedicine flexibilities (hereinafter, “telemedicine flexibilities”) for six months following the end of the PHE (through November 11, 2023). Still, telemedicine providers should closely monitor for the DEA’s final rules, once they are issued.

COVID-19 40

COVID-19 Telemedicine Health Services Administration Public Health 40

Healthcare Law Today

NOVEMBER 9, 2022

Prior to the federal COVID-19 Public Health Emergency (PHE), to initiate treatment with buprenorphine at an OTP, a practitioner needed to perform a complete in-person physical evaluation. Background and History of Medicare Telehealth Coverage of SUD Treatment. Want to Learn More?

Medicare 52

Medicare Medicare COVID-19 Telemedicine 52